Global Nosocomial Infection Treatment Market Size, Status and Forecast 2021-2027

SKU ID : QYR-17768718 | Publishing Date : 22-Mar-2021 | No. of pages : 125

Request Sample

Pre-order Enquiry

Request Customization

Check Discounts

Request a free Sample

Detailed TOC of Global Nosocomial Infection Treatment Market Size, Status and Forecast 2021-2027

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Nosocomial Infection Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Antibacterial Treatment
        1.2.3 Antiviral Treatment
        1.2.4 Antifungal Treatment
    1.3 Market by Application
        1.3.1 Global Nosocomial Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Ventilator Associated Pneumonia
        1.3.3 Urinary Tract Infection
        1.3.4 Blood Stream Infection
        1.3.5 Surgical Site Infection
        1.3.6 Gastrointestinal Infection
        1.3.7 MRSA
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Nosocomial Infection Treatment Market Perspective (2016-2027)
    2.2 Nosocomial Infection Treatment Growth Trends by Regions
        2.2.1 Nosocomial Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Nosocomial Infection Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Nosocomial Infection Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Nosocomial Infection Treatment Industry Dynamic
        2.3.1 Nosocomial Infection Treatment Market Trends
        2.3.2 Nosocomial Infection Treatment Market Drivers
        2.3.3 Nosocomial Infection Treatment Market Challenges
        2.3.4 Nosocomial Infection Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Nosocomial Infection Treatment Players by Revenue
        3.1.1 Global Top Nosocomial Infection Treatment Players by Revenue (2016-2021)
        3.1.2 Global Nosocomial Infection Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Nosocomial Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Nosocomial Infection Treatment Revenue
    3.4 Global Nosocomial Infection Treatment Market Concentration Ratio
        3.4.1 Global Nosocomial Infection Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Nosocomial Infection Treatment Revenue in 2020
    3.5 Nosocomial Infection Treatment Key Players Head office and Area Served
    3.6 Key Players Nosocomial Infection Treatment Product Solution and Service
    3.7 Date of Enter into Nosocomial Infection Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Nosocomial Infection Treatment Breakdown Data by Type
    4.1 Global Nosocomial Infection Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Nosocomial Infection Treatment Forecasted Market Size by Type (2022-2027)

5 Nosocomial Infection Treatment Breakdown Data by Application
    5.1 Global Nosocomial Infection Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Nosocomial Infection Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Nosocomial Infection Treatment Market Size (2016-2027)
    6.2 North America Nosocomial Infection Treatment Market Size by Type
        6.2.1 North America Nosocomial Infection Treatment Market Size by Type (2016-2021)
        6.2.2 North America Nosocomial Infection Treatment Market Size by Type (2022-2027)
        6.2.3 North America Nosocomial Infection Treatment Market Size by Type (2016-2027)
    6.3 North America Nosocomial Infection Treatment Market Size by Application
        6.3.1 North America Nosocomial Infection Treatment Market Size by Application (2016-2021)
        6.3.2 North America Nosocomial Infection Treatment Market Size by Application (2022-2027)
        6.3.3 North America Nosocomial Infection Treatment Market Size by Application (2016-2027)
    6.4 North America Nosocomial Infection Treatment Market Size by Country
        6.4.1 North America Nosocomial Infection Treatment Market Size by Country (2016-2021)
        6.4.2 North America Nosocomial Infection Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Nosocomial Infection Treatment Market Size (2016-2027)
    7.2 Europe Nosocomial Infection Treatment Market Size by Type
        7.2.1 Europe Nosocomial Infection Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Nosocomial Infection Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Nosocomial Infection Treatment Market Size by Type (2016-2027)
    7.3 Europe Nosocomial Infection Treatment Market Size by Application
        7.3.1 Europe Nosocomial Infection Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Nosocomial Infection Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Nosocomial Infection Treatment Market Size by Application (2016-2027)
    7.4 Europe Nosocomial Infection Treatment Market Size by Country
        7.4.1 Europe Nosocomial Infection Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Nosocomial Infection Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Nosocomial Infection Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Nosocomial Infection Treatment Market Size by Type
        8.2.1 Asia-Pacific Nosocomial Infection Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Nosocomial Infection Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Nosocomial Infection Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Nosocomial Infection Treatment Market Size by Application
        8.3.1 Asia-Pacific Nosocomial Infection Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Nosocomial Infection Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Nosocomial Infection Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Nosocomial Infection Treatment Market Size by Region
        8.4.1 Asia-Pacific Nosocomial Infection Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Nosocomial Infection Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Nosocomial Infection Treatment Market Size (2016-2027)
    9.2 Latin America Nosocomial Infection Treatment Market Size by Type
        9.2.1 Latin America Nosocomial Infection Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Nosocomial Infection Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Nosocomial Infection Treatment Market Size by Type (2016-2027)
    9.3 Latin America Nosocomial Infection Treatment Market Size by Application
        9.3.1 Latin America Nosocomial Infection Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Nosocomial Infection Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Nosocomial Infection Treatment Market Size by Application (2016-2027)
    9.4 Latin America Nosocomial Infection Treatment Market Size by Country
        9.4.1 Latin America Nosocomial Infection Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Nosocomial Infection Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Nosocomial Infection Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Nosocomial Infection Treatment Market Size by Type
        10.2.1 Middle East & Africa Nosocomial Infection Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Nosocomial Infection Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Nosocomial Infection Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Nosocomial Infection Treatment Market Size by Application
        10.3.1 Middle East & Africa Nosocomial Infection Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Nosocomial Infection Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Nosocomial Infection Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Nosocomial Infection Treatment Market Size by Country
        10.4.1 Middle East & Africa Nosocomial Infection Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Nosocomial Infection Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Nosocomial Infection Treatment Introduction
        11.1.4 Abbott Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.1.5 Abbott Recent Development
    11.2 Bayer
        11.2.1 Bayer Company Details
        11.2.2 Bayer Business Overview
        11.2.3 Bayer Nosocomial Infection Treatment Introduction
        11.2.4 Bayer Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.2.5 Bayer Recent Development
    11.3 Becton, Dickinson and Company
        11.3.1 Becton, Dickinson and Company Company Details
        11.3.2 Becton, Dickinson and Company Business Overview
        11.3.3 Becton, Dickinson and Company Nosocomial Infection Treatment Introduction
        11.3.4 Becton, Dickinson and Company Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.3.5 Becton, Dickinson and Company Recent Development
    11.4 Belimed
        11.4.1 Belimed Company Details
        11.4.2 Belimed Business Overview
        11.4.3 Belimed Nosocomial Infection Treatment Introduction
        11.4.4 Belimed Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.4.5 Belimed Recent Development
    11.5 BioMerieux
        11.5.1 BioMerieux Company Details
        11.5.2 BioMerieux Business Overview
        11.5.3 BioMerieux Nosocomial Infection Treatment Introduction
        11.5.4 BioMerieux Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.5.5 BioMerieux Recent Development
    11.6 Cantel
        11.6.1 Cantel Company Details
        11.6.2 Cantel Business Overview
        11.6.3 Cantel Nosocomial Infection Treatment Introduction
        11.6.4 Cantel Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.6.5 Cantel Recent Development
    11.7 Cepheid
        11.7.1 Cepheid Company Details
        11.7.2 Cepheid Business Overview
        11.7.3 Cepheid Nosocomial Infection Treatment Introduction
        11.7.4 Cepheid Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.7.5 Cepheid Recent Development
    11.8 Getinge Group
        11.8.1 Getinge Group Company Details
        11.8.2 Getinge Group Business Overview
        11.8.3 Getinge Group Nosocomial Infection Treatment Introduction
        11.8.4 Getinge Group Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.8.5 Getinge Group Recent Development
    11.9 Kimberly-Clark Corp.
        11.9.1 Kimberly-Clark Corp. Company Details
        11.9.2 Kimberly-Clark Corp. Business Overview
        11.9.3 Kimberly-Clark Corp. Nosocomial Infection Treatment Introduction
        11.9.4 Kimberly-Clark Corp. Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.9.5 Kimberly-Clark Corp. Recent Development
    11.10 Merck & Co
        11.10.1 Merck & Co Company Details
        11.10.2 Merck & Co Business Overview
        11.10.3 Merck & Co Nosocomial Infection Treatment Introduction
        11.10.4 Merck & Co Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.10.5 Merck & Co Recent Development
    11.11 Nordion
        11.11.1 Nordion Company Details
        11.11.2 Nordion Business Overview
        11.11.3 Nordion Nosocomial Infection Treatment Introduction
        11.11.4 Nordion Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.11.5 Nordion Recent Development
    11.12 Pfizer
        11.12.1 Pfizer Company Details
        11.12.2 Pfizer Business Overview
        11.12.3 Pfizer Nosocomial Infection Treatment Introduction
        11.12.4 Pfizer Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.12.5 Pfizer Recent Development
    11.13 Roche
        11.13.1 Roche Company Details
        11.13.2 Roche Business Overview
        11.13.3 Roche Nosocomial Infection Treatment Introduction
        11.13.4 Roche Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.13.5 Roche Recent Development
    11.14 Sakura Seiki
        11.14.1 Sakura Seiki Company Details
        11.14.2 Sakura Seiki Business Overview
        11.14.3 Sakura Seiki Nosocomial Infection Treatment Introduction
        11.14.4 Sakura Seiki Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.14.5 Sakura Seiki Recent Development
    11.15 BioMérieux
        11.15.1 BioMérieux Company Details
        11.15.2 BioMérieux Business Overview
        11.15.3 BioMérieux Nosocomial Infection Treatment Introduction
        11.15.4 BioMérieux Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.15.5 BioMérieux Recent Development
    11.16 Steris
        11.16.1 Steris Company Details
        11.16.2 Steris Business Overview
        11.16.3 Steris Nosocomial Infection Treatment Introduction
        11.16.4 Steris Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.16.5 Steris Recent Development
    11.17 Johnson & Johnson
        11.17.1 Johnson & Johnson Company Details
        11.17.2 Johnson & Johnson Business Overview
        11.17.3 Johnson & Johnson Nosocomial Infection Treatment Introduction
        11.17.4 Johnson & Johnson Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.17.5 Johnson & Johnson Recent Development
    11.18 Sterigenics International, Inc.
        11.18.1 Sterigenics International, Inc. Company Details
        11.18.2 Sterigenics International, Inc. Business Overview
        11.18.3 Sterigenics International, Inc. Nosocomial Infection Treatment Introduction
        11.18.4 Sterigenics International, Inc. Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.18.5 Sterigenics International, Inc. Recent Development
    11.18 Halyard Health, Inc.
        .1 Halyard Health, Inc. Company Details
        .2 Halyard Health, Inc. Business Overview
        .3 Halyard Health, Inc. Nosocomial Infection Treatment Introduction
        .4 Halyard Health, Inc. Revenue in Nosocomial Infection Treatment Business (2016-2021)
        .5 Halyard Health, Inc. Recent Development
    11.20 Advanced Sterilization Products
        11.20.1 Advanced Sterilization Products Company Details
        11.20.2 Advanced Sterilization Products Business Overview
        11.20.3 Advanced Sterilization Products Nosocomial Infection Treatment Introduction
        11.20.4 Advanced Sterilization Products Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.20.5 Advanced Sterilization Products Recent Development
    11.21 Matachana Group
        11.21.1 Matachana Group Company Details
        11.21.2 Matachana Group Business Overview
        11.21.3 Matachana Group Nosocomial Infection Treatment Introduction
        11.21.4 Matachana Group Revenue in Nosocomial Infection Treatment Business (2016-2021)
        11.21.5 Matachana Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Nosocomial Infection Treatment Market Size, Status and Forecast 2021-2027

List of Tables
    Table 1. Global Nosocomial Infection Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Antibacterial Treatment
    Table 3. Key Players of Antiviral Treatment
    Table 4. Key Players of Antifungal Treatment
    Table 5. Global Nosocomial Infection Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Nosocomial Infection Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Nosocomial Infection Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Nosocomial Infection Treatment Market Share by Regions (2016-2021)
    Table 9. Global Nosocomial Infection Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Nosocomial Infection Treatment Market Share by Regions (2022-2027)
    Table 11. Nosocomial Infection Treatment Market Trends
    Table 12. Nosocomial Infection Treatment Market Drivers
    Table 13. Nosocomial Infection Treatment Market Challenges
    Table 14. Nosocomial Infection Treatment Market Restraints
    Table 15. Global Nosocomial Infection Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Nosocomial Infection Treatment Market Share by Players (2016-2021)
    Table 17. Global Top Nosocomial Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nosocomial Infection Treatment as of 2020)
    Table 18. Ranking of Global Top Nosocomial Infection Treatment Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Nosocomial Infection Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Nosocomial Infection Treatment Product Solution and Service
    Table 22. Date of Enter into Nosocomial Infection Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Nosocomial Infection Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Nosocomial Infection Treatment Revenue Market Share by Type (2016-2021)
    Table 26. Global Nosocomial Infection Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Nosocomial Infection Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Nosocomial Infection Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Nosocomial Infection Treatment Revenue Market Share by Application (2016-2021)
    Table 30. Global Nosocomial Infection Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Nosocomial Infection Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Nosocomial Infection Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Nosocomial Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Nosocomial Infection Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Nosocomial Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Nosocomial Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 37. North America Nosocomial Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 38. Europe Nosocomial Infection Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Nosocomial Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Nosocomial Infection Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Nosocomial Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Nosocomial Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 43. Europe Nosocomial Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 44. Asia-Pacific Nosocomial Infection Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Nosocomial Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Nosocomial Infection Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Nosocomial Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Nosocomial Infection Treatment Market Size by Region (2016-2021) & (US$ Million)
    Table 49. Asia-Pacific Nosocomial Infection Treatment Market Size by Region (2022-2027) & (US$ Million)
    Table 50. Latin America Nosocomial Infection Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Nosocomial Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Nosocomial Infection Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Nosocomial Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Nosocomial Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 55. Latin America Nosocomial Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 56. Middle East & Africa Nosocomial Infection Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Nosocomial Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Nosocomial Infection Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Nosocomial Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Nosocomial Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 61. Middle East & Africa Nosocomial Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 62. Abbott Company Details
    Table 63. Abbott Business Overview
    Table 64. Abbott Nosocomial Infection Treatment Product
    Table 65. Abbott Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 66. Abbott Recent Development
    Table 67. Bayer Company Details
    Table 68. Bayer Business Overview
    Table 69. Bayer Nosocomial Infection Treatment Product
    Table 70. Bayer Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 71. Bayer Recent Development
    Table 72. Becton, Dickinson and Company Company Details
    Table 73. Becton, Dickinson and Company Business Overview
    Table 74. Becton, Dickinson and Company Nosocomial Infection Treatment Product
    Table 75. Becton, Dickinson and Company Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 76. Becton, Dickinson and Company Recent Development
    Table 77. Belimed Company Details
    Table 78. Belimed Business Overview
    Table 79. Belimed Nosocomial Infection Treatment Product
    Table 80. Belimed Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 81. Belimed Recent Development
    Table 82. BioMerieux Company Details
    Table 83. BioMerieux Business Overview
    Table 84. BioMerieux Nosocomial Infection Treatment Product
    Table 85. BioMerieux Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 86. BioMerieux Recent Development
    Table 87. Cantel Company Details
    Table 88. Cantel Business Overview
    Table 89. Cantel Nosocomial Infection Treatment Product
    Table 90. Cantel Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 91. Cantel Recent Development
    Table 92. Cepheid Company Details
    Table 93. Cepheid Business Overview
    Table 94. Cepheid Nosocomial Infection Treatment Product
    Table 95. Cepheid Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 96. Cepheid Recent Development
    Table 97. Getinge Group Company Details
    Table 98. Getinge Group Business Overview
    Table 99. Getinge Group Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 100. Getinge Group Recent Development
    Table 101. Kimberly-Clark Corp. Company Details
    Table 102. Kimberly-Clark Corp. Business Overview
    Table 103. Kimberly-Clark Corp. Nosocomial Infection Treatment Product
    Table 104. Kimberly-Clark Corp. Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 105. Kimberly-Clark Corp. Recent Development
    Table 106. Merck & Co Company Details
    Table 107. Merck & Co Business Overview
    Table 108. Merck & Co Nosocomial Infection Treatment Product
    Table 109. Merck & Co Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 110. Merck & Co Recent Development
    Table 111. Nordion Company Details
    Table 112. Nordion Business Overview
    Table 113. Nordion Nosocomial Infection Treatment Product
    Table 114. Nordion Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 115. Nordion Recent Development
    Table 116. Pfizer Company Details
    Table 117. Pfizer Business Overview
    Table 118. Pfizer Nosocomial Infection Treatment Product
    Table 119. Pfizer Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 120. Pfizer Recent Development
    Table 121. Roche Company Details
    Table 122. Roche Business Overview
    Table 123. Roche Nosocomial Infection Treatment Product
    Table 124. Roche Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 125. Roche Recent Development
    Table 126. Sakura Seiki Company Details
    Table 127. Sakura Seiki Business Overview
    Table 128. Sakura Seiki Nosocomial Infection Treatment Product
    Table 129. Sakura Seiki Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 130. Sakura Seiki Recent Development
    Table 131. BioMérieux Company Details
    Table 132. BioMérieux Business Overview
    Table 133. BioMérieux Nosocomial Infection Treatment Product
    Table 134. BioMérieux Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 135. BioMérieux Recent Development
    Table 136. Steris Company Details
    Table 137. Steris Business Overview
    Table 138. Steris Nosocomial Infection Treatment Product
    Table 139. Steris Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 140. Steris Recent Development
    Table 141. Johnson & Johnson Company Details
    Table 142. Johnson & Johnson Business Overview
    Table 143. Johnson & Johnson Nosocomial Infection Treatment Product
    Table 144. Johnson & Johnson Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 145. Johnson & Johnson Recent Development
    Table 146. Sterigenics International, Inc. Company Details
    Table 147. Sterigenics International, Inc. Business Overview
    Table 148. Sterigenics International, Inc. Nosocomial Infection Treatment Product
    Table 149. Sterigenics International, Inc. Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 150. Sterigenics International, Inc. Recent Development
    Table 151. Halyard Health, Inc. Company Details
    Table 152. Halyard Health, Inc. Business Overview
    Table 153. Halyard Health, Inc. Nosocomial Infection Treatment Product
    Table 154. Halyard Health, Inc. Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 155. Halyard Health, Inc. Recent Development
    Table 156. Advanced Sterilization Products Company Details
    Table 157. Advanced Sterilization Products Business Overview
    Table 158. Advanced Sterilization Products Nosocomial Infection Treatment Product
    Table 159. Advanced Sterilization Products Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 160. Advanced Sterilization Products Recent Development
    Table 161. Matachana Group Company Details
    Table 162. Matachana Group Business Overview
    Table 163. Matachana Group Nosocomial Infection Treatment Product
    Table 164. Matachana Group Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million)
    Table 165. Matachana Group Recent Development
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Nosocomial Infection Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Antibacterial Treatment Features
    Figure 3. Antiviral Treatment Features
    Figure 4. Antifungal Treatment Features
    Figure 5. Global Nosocomial Infection Treatment Market Share by Application: 2020 VS 2027
    Figure 6. Ventilator Associated Pneumonia Case Studies
    Figure 7. Urinary Tract Infection Case Studies
    Figure 8. Blood Stream Infection Case Studies
    Figure 9. Surgical Site Infection Case Studies
    Figure 10. Gastrointestinal Infection Case Studies
    Figure 11. MRSA Case Studies
    Figure 12. Nosocomial Infection Treatment Report Years Considered
    Figure 13. Global Nosocomial Infection Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Nosocomial Infection Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Nosocomial Infection Treatment Market Share by Regions: 2020 VS 2027
    Figure 16. Global Nosocomial Infection Treatment Market Share by Regions (2022-2027)
    Figure 17. Global Nosocomial Infection Treatment Market Share by Players in 2020
    Figure 18. Global Top Nosocomial Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nosocomial Infection Treatment as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Nosocomial Infection Treatment Revenue in 2020
    Figure 20. Global Nosocomial Infection Treatment Revenue Market Share by Type (2016-2021)
    Figure 21. Global Nosocomial Infection Treatment Revenue Market Share by Type (2022-2027)
    Figure 22. North America Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Nosocomial Infection Treatment Market Share by Type (2016-2027)
    Figure 24. North America Nosocomial Infection Treatment Market Share by Application (2016-2027)
    Figure 25. North America Nosocomial Infection Treatment Market Share by Country (2016-2027)
    Figure 26. United States Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Nosocomial Infection Treatment Market Share by Type (2016-2027)
    Figure 30. Europe Nosocomial Infection Treatment Market Share by Application (2016-2027)
    Figure 31. Europe Nosocomial Infection Treatment Market Share by Country (2016-2027)
    Figure 32. Germany Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Nosocomial Infection Treatment Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Nosocomial Infection Treatment Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Nosocomial Infection Treatment Market Share by Region (2016-2027)
    Figure 42. China Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Nosocomial Infection Treatment Market Share by Type (2016-2027)
    Figure 50. Latin America Nosocomial Infection Treatment Market Share by Application (2016-2027)
    Figure 51. Latin America Nosocomial Infection Treatment Market Share by Country (2016-2027)
    Figure 52. Mexico Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Nosocomial Infection Treatment Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Nosocomial Infection Treatment Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Nosocomial Infection Treatment Market Share by Country (2016-2027)
    Figure 58. Turkey Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Abbott Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 62. Bayer Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 63. Becton, Dickinson and Company Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 64. Belimed Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 65. BioMerieux Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 66. Cantel Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 67. Cepheid Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 68. Getinge Group Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 69. Kimberly-Clark Corp. Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 70. Merck & Co Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 71. Nordion Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 72. Pfizer Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 73. Roche Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 74. Sakura Seiki Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 75. BioMérieux Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 76. Steris Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 77. Johnson & Johnson Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 78. Sterigenics International, Inc. Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 79. Halyard Health, Inc. Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 80. Advanced Sterilization Products Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 81. Matachana Group Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021)
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed

Keyplayers in Global Nosocomial Infection Treatment Market Size, Status and Forecast 2021-2027

Abbott
Bayer
Becton, Dickinson and Company
Belimed
BioMerieux
Cantel
Cepheid
Getinge Group
Kimberly-Clark Corp.
Merck & Co
Nordion
Pfizer
Roche
Sakura Seiki
BioMérieux
Steris
Johnson & Johnson
Sterigenics International, Inc.
Halyard Health, Inc.
Advanced Sterilization Products
Matachana Group

Global Nosocomial Infection Treatment Market Size, Status and Forecast 2021-2027

Detailed TOC of Global Nosocomial Infection Treatment Market Size, Status and Forecast 2021-2027

List of Figures, Tables and Charts Available in Global Nosocomial Infection Treatment Market Size, Status and Forecast 2021-2027

Keyplayers in Global Nosocomial Infection Treatment Market Size, Status and Forecast 2021-2027

REQUEST SUMMARY

Our Clients